Johnson & Johnson ( JNJ) - Stock Earnings
JNJ Upcoming earnings
Estimated EPS and revenue columns are available to paid members.
| Date | EPS (actual / est.) | Revenue low (est.) | Revenue (actual / est.) | Revenue high (est.) |
|---|---|---|---|---|
| Oct. 13, 2026, midnight | — / — | — | — / — | — |
JNJ Quarterly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2025Q4 | 5.1 billion USD | 24.6 billion USD |
| 2026Q1 | 5.2 billion USD | 24.1 billion USD |
| 2026Q2 | 5.5 billion USD | 25.3 billion USD |
| 2026Q4 Est. | — | — |
| 2027Q1 Est. | — | — |
| 2027Q2 Est. | — | — |
JNJ Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | 35.2 billion USD | 85.2 billion USD |
| 2024 | 14.1 billion USD | 88.8 billion USD |
| 2025 | 26.8 billion USD | 94.2 billion USD |
| 2026 Est. | — | — |
JNJ
List: Champions
Price: $260.42
Dividend Yield: 1.90%
Forward Dividend Yield: 2.02%
Payout Ratio: 75.04%
Dividend Per Share: 5.36 USD
Earnings Per Share: 8.67 USD
P/E Ratio: 28.91
Exchange: NYQ
Sector: Healthcare
Industry: Drug Manufacturers - General
Country: United States
Volume: 6.9 million
Ebitda: 2.9 billionMarket Capitalization: 671.4 billion
Average Dividend Frequency: 4
Years Paying Dividends: 26
DGR3: 5.07%
DGR5: 5.32%
DGR10: 5.77%
DGR20: 7.38%